An overexpression of NEK9-Eg5 is recorded in patients with colon adenocarcinoma along with a distant metastasis association, thus representing a new possible biomarker to predict the metastatic potential in patients with T3 colon cancer [33]. Here, KIF11 is linked to malignant colon neoplasm.